BMS-986016

· Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986016, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors [Phase 1]